Michael J. Detke Cortexyme, Inc. (CRTX) insider trading activity

Michael J. Detke is Chief Medical Officer of Cortexyme, Inc.. Currently has a direct ownership of 140,000 shares of CRTX, which is worth approximately $180,600. The most recent transaction as insider was on Mar 03, 2022, when has been sold 140,000 shares (Common Stock) at a price of $0.0 per share, resulting in proceeds of $0. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 140K

0% 3M change

0% 12M change

Total Value Held $180,600

Michael J. Detke Transaction History

Date	Transaction	Value	Shares Traded	Shares Held
Mar 03 2022	BUY Grant, award, or other acquisition	-	140,000 Added 50.0%	140,000 Common Stock
Aug 10 2021	SELL Open market or private sale	$1,000,000 $100.0 p/Share	10,000 Reduced 100.0%	0 Common Stock
Aug 10 2021	BUY Exercise of conversion of derivative security	$22,300 $2.23 p/Share	10,000 Added 50.0%	10,000 Common Stock
Jul 07 2021	SELL Open market or private sale	$961,350 $55.25 p/Share	17,400 Reduced 100.0%	0 Common Stock
Jul 07 2021	BUY Exercise of conversion of derivative security	$38,802 $2.23 p/Share	17,400 Added 50.0%	17,400 Common Stock
Jul 06 2021	SELL Open market or private sale	$2,211,397 $54.12 p/Share	40,861 Reduced 100.0%	0 Common Stock
Jul 06 2021	BUY Exercise of conversion of derivative security	$28,098 $2.23 p/Share	12,600 Added 23.57%	40,861 Common Stock

MJD

Michael J. Detke

Chief Medical Officer

South San Francisco, CA

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells CRTX shares.

Notify only if

Value

Insider Trading

Get notified when an Cortexyme, Inc. insider buys or sells CRTX shares.

Notify only if

Operation

Value

Type

News

Receive news related to Cortexyme, Inc.

Track Activities on CRTX

Account